Discontinuation of Levemir (insulin detemir) - abbreviated ABCD/PCDOS guidance.
| Publicado en: | Diabetes & Primary Care Vol. 28; no. 3; pp. 99 - 104 |
|---|---|
| Autores principales: | , |
| Formato: | practice guidelines tables/charts Journal Article |
| Publicado: |
SB Communications Group, A Schofield Media Company
2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195569103&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195569103 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14668955 IS1 jtl: Diabetes & Primary Care issn: 14668955 maglogo: N pubinfo: dt: 2026 vid: 28 iid: 3 pid: 13783 pub: SB Communications Group, A Schofield Media Company artinfo: ui: 195569103 195569103 195569103 195569103 ppf: 99 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Discontinuation of Levemir (insulin detemir) - abbreviated ABCD/PCDOS guidance. aug: au: Milne, Nicola Lewis, Julie sug: subj: Insulin, Long-Acting Administration and Dosage Diabetes Mellitus Drug Therapy Practice Guidelines Primary Health Care Insulin, Long-Acting Therapeutic Use Patient Safety Standards Insulin, Long-Acting Supply and Distribution Drug Substitution Information Resources pubtype: Academic Journal doctype: practice guidelines tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|